drugset / Trial / NCT02071199

Treatment of Human Gingivitis With Amnion-derived Cellular Cytokine Solution (ACCS)

NCT02071199 ↗

Phase 1 Completed 54 enrolled Noveome Biotherapeutics
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety of oral topical application of Amnion-derived Cellular Cytokine Solution (ACCS) in subjects with gingivitis

Timeline

Start
2014-03
Primary completion
2015-10
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject ACCS Unknown 0.3 unknown Topical
Subject ACCS Unknown 0.3 unknown Topical
Subject ACCS Unknown 1 unknown Topical

Indications